Dhananjaya Dendukuri

Dr. Dhananjaya Dendukuri is the Chief Executive Officer and Co-Founder of Achira Labs. He returned to India driven by his passion for engineering and the belief that technology development for underserved markets must be done locally. Achira is a pioneering Indian company translating cutting-edge microfluidics technologies into industrial practice for medical devices and diagnostics. The company has built India’s first microfluidics-based platform for point-of-care immunodiagnostics and created the world’s first woven-fabric-based point-of-care platform. Achira develops products for a range of diagnostic applications, including infectious diseases and metabolic health.

Dr. Dendukuri’s research and entrepreneurial work are backed by over 30 international patents, several peer-reviewed publications and national and international government-funded projects. Research at Achira is supported by prominent partners including Cipla, Catamaran, the Bill & Melinda Gates Foundation (BMGF), and the Biotechnology Industry Research Assistance Council (BIRAC). He has been recognized with several honors, including the MIT Technology Review’s TR35 Award, the National Technology Award for New Technologies, and is an elected Fellow of the Indian National Academy of Engineering.

He holds a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology (MIT), an M.A.Sc. in Chemical Engineering from the University of Toronto, and a B.Tech. in Chemical Engineering from the Indian Institute of Technology, Madras, where he received the Institute Blue.